Ignite Creation Date:
2025-12-25 @ 12:38 AM
Ignite Modification Date:
2025-12-29 @ 9:02 PM
Study NCT ID:
NCT00492167
Status:
COMPLETED
Last Update Posted:
2022-03-07
First Post:
2007-06-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Beta-Glucan and Monoclonal Antibody 3F8 in Treating Patients With Metastatic Neuroblastoma
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-09-09
Start Date Type:
ACTUAL
Primary Completion Date:
2022-03-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-03-04
Completion Date Type:
ACTUAL
First Submit Date:
2007-06-25
First Submit QC Date:
None
Study First Post Date:
2007-06-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-03-04
Last Update Post Date:
2022-03-07
Last Update Post Date Type:
ACTUAL